New Report from ARM Provides Overview of the Regenerative Medicine Landscape for Rare Disease

Rare Disease & Regenerative Medicine 2019 This report provides industry specific statistics compiled from cell therapy, gene therapy, tissue engineering, and other regenerative medicine companies active in developing therapies for rare disease and provides context for the potential of regenerative medicine to improve upon the current standard of care.


Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19

APN01, developed based on the work of UBC’s Josef Penninger, already shown to block viral spread in SARS A University of British Columbia researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in Guangzhou, China. Dr.

Read More


The first clinical trial for a new COVID-19 vaccine developed by a U.S. biotech firm will begin in April at NIAID’s clinical-trials unit in Bethesda

n Monday, when China reported 409 new cases of COVID-19 infection and 150 more deaths, Massachusetts-based biotechnology company Moderna, Inc. delivered the first batch of its rapidly developed coronavirus vaccine to the U.S. National Institutes of Health (NIH). As of early Tuesday afternoon, Hong Kong time, there are 80,147 confirmed cases of COVID-19 and 2,699 deaths. In

Read More


News about Vaccine Technologies Deployed to Develop COVID-19 Shot

Researchers look to messenger RNA encased in nanoparticles, DNA plasmids, molecular clamps and other approaches as they rush to design a vaccine against the new coronavirus. The Chinese Center for Disease Control and Prevention reported on February 20 that the novel coronavirus illness known as COVID-19 has now infected nearly 75,000 people and that the number of fatalities in

Read More


Tackling the Challenges in Cell and Gene Therapy Manufacturing

The excitement about cell and gene therapies is almost tangible within the biotech and pharma industry. Over 950 companies are actively developing advanced therapies, which are expected to make exceptional improvements to peoples’ lives in the next decade. Although hopes are high, the industry still faces a number of challenges in cell and gene therapy manufacturing, mainly

Read More


Report claims two-thirds of global coronavirus cases have gone undetected

A new report from a WHO infectious disease modeling team based at Imperial College London is estimating about two-thirds of Covid-19 cases worldwide have gone undetected. The analysis suggests the global spread of the novel coronavirus is significantly greater than the current volume of confirmed cases. Source: Imperial College London “We are starting to see more

Read More